Explore approved biosimilar medicines
| # | Medicine | Status | Active Substance | Therapeutic Area | Developer | Published Date |
|---|---|---|---|---|---|---|
| 21 | Kanjinti | Authorised | trastuzumab | Stomach Neoplasms;Breast Neoplasms | Amgen Europe B.V. | 17-08-2018 |
| 22 | Afiveg | Authorised | aflibercept | Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | STADA Arzneimittel AG | 20-06-2025 |
| 23 | Uzpruvo | Authorised | ustekinumab | Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | Stada Arzneimittel AG | 10-11-2023 |
| 24 | Usgena | Authorised | ustekinumab | Crohn Disease;Psoriasis;Arthritis, Psoriatic;Colitis, Ulcerative | Stada Arzneimittel AG | 19-09-2025 |
| 25 | Dazublys | Authorised | trastuzumab | Breast Neoplasms;Stomach Neoplasms | CuraTeQ Biologics s.r.o | 12-08-2025 |
| 26 | Ondibta | Authorised | insulin glargine | Diabetes Mellitus | Gan & Lee Pharmaceuticals Europe GmbH | 14-11-2025 |
| 27 | Rexatilux | Opinion | ranibizumab | Wet Macular Degeneration | Intas Third Party Sales 2005 S.L. | 24-04-2026 |
| 28 | Vysribli (previously Denosumab Intas) | Authorised | denosumab | Bone Resorption;Osteoporosis;Osteoporosis, Postmenopausal | Intas Third Party Sales 2005 S.L. | 19-09-2025 |
| 29 | Terrosa | Authorised | teriparatide | Osteoporosis | Gedeon Richter Plc. | 23-02-2018 |
| 30 | Amgevita | Authorised | adalimumab | Arthritis, Psoriatic;Colitis, Ulcerative;Arthritis, Juvenile Rheumatoid;Spondylitis, Ankylosing;Psoriasis;Crohn Disease;Arthritis, Rheumatoid | Amgen Europe B.V. | 20-07-2018 |
Ready to transform your strategic intelligence? Let's talk
Get latest pharmaceutical insights, blogs, and strategic updates directly in your inbox.